Cargando…
P832: CLINICAL OUTCOMES AND IMMUNE RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH SEVERE APLASTIC ANEMIA
Autores principales: | Rajput, R., Ma, X., Boswell, K. L., Gaudinski, M., Groarke, E. M., Lotter, J., Rios, O., Darden, I., Wu, C. O., Koup, R. A., Young, N. S., Patel, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428999/ http://dx.doi.org/10.1097/01.HS9.0000846212.02590.17 |
Ejemplares similares
-
P805: ALEMTUZUMAB IN RELAPSED SEVERE APLASTIC ANEMIA: LONG-TERM RESULTS OF A PHASE II STUDY
por: Aggarwal, N., et al.
Publicado: (2022) -
Detectable mutations precede late myeloid neoplasia in aplastic anemia
por: Patel, Bhavisha A., et al.
Publicado: (2020) -
P807: APLASTIC ANEMIA FOLLOWING THE SARS-COV-2 VACCINE
por: Babakhanlou, R., et al.
Publicado: (2022) -
COVID‐19 infection in patients with severe aplastic anaemia
por: Paton, Casey, et al.
Publicado: (2021) -
S184: SAFETY AND OUTCOMES FOLLOWING IMMUNOSUPPRESSIVE THERAPY WITH ATG/CYCLOSPORIN +/- ELTROMBOPAG FOR OLDER PATIENTS WITH SEVERE APLASTIC ANEMIA
por: Prabahran, Ashvind, et al.
Publicado: (2023)